Shize Pan

446 total citations
19 papers, 307 citations indexed

About

Shize Pan is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shize Pan has authored 19 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 9 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shize Pan's work include Cancer-related molecular mechanisms research (7 papers), Ferroptosis and cancer prognosis (7 papers) and Autophagy in Disease and Therapy (5 papers). Shize Pan is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Ferroptosis and cancer prognosis (7 papers) and Autophagy in Disease and Therapy (5 papers). Shize Pan collaborates with scholars based in China. Shize Pan's co-authors include Qing Geng, Congkuan Song, Jinjin Zhang, Ning Li, Donghang Li, Tao Fan, Zhangfan Mao, Bo Hao, Boyou Zhang and Yao Xu and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and European Journal of Pharmacology.

In The Last Decade

Shize Pan

18 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shize Pan China 10 181 87 79 73 54 19 307
Meiyu Zhang China 9 169 0.9× 24 0.3× 61 0.8× 82 1.1× 43 0.8× 26 299
Manali Dimri United States 6 227 1.3× 54 0.6× 107 1.4× 54 0.7× 55 1.0× 10 401
Shulin Wu China 6 343 1.9× 79 0.9× 103 1.3× 41 0.6× 40 0.7× 10 484
Shuoyi Jiang China 9 289 1.6× 124 1.4× 73 0.9× 30 0.4× 80 1.5× 12 439
Kuo-Hao Ho Taiwan 14 326 1.8× 52 0.6× 260 3.3× 54 0.7× 51 0.9× 19 485
Peng-Hsu Chen Taiwan 12 288 1.6× 51 0.6× 245 3.1× 44 0.6× 42 0.8× 15 429
Hongjuan Cui China 11 305 1.7× 31 0.4× 89 1.1× 40 0.5× 59 1.1× 19 405
Bor Jang Hwang United States 4 379 2.1× 83 1.0× 236 3.0× 33 0.5× 67 1.2× 4 501

Countries citing papers authored by Shize Pan

Since Specialization
Citations

This map shows the geographic impact of Shize Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shize Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shize Pan more than expected).

Fields of papers citing papers by Shize Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shize Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shize Pan. The network helps show where Shize Pan may publish in the future.

Co-authorship network of co-authors of Shize Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Shize Pan. A scholar is included among the top collaborators of Shize Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shize Pan. Shize Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Li, Donghang, Wei Wang, Congkuan Song, et al.. (2023). Eriocitrin attenuates sepsis-induced acute lung injury in mice by regulating MKP1/MAPK pathway mediated-glycolysis. International Immunopharmacology. 118. 110021–110021. 28 indexed citations
2.
Lu, Zilong, et al.. (2023). Hydroxycitric Acid Alleviated Lung Ischemia-Reperfusion Injury by Inhibiting Oxidative Stress and Ferroptosis through the Hif-1α Pathway. Current Issues in Molecular Biology. 45(12). 9868–9886. 6 indexed citations
3.
Song, Congkuan, X. Shirley Liu, Wei‐Chen Lin, et al.. (2023). Systematic analysis of histone acetylation regulators across human cancers. BMC Cancer. 23(1). 733–733. 5 indexed citations
5.
Song, Congkuan, Shize Pan, Jinjin Zhang, Ning Li, & Qing Geng. (2022). Mitophagy: A novel perspective for insighting into cancer and cancer treatment. Cell Proliferation. 55(12). e13327–e13327. 71 indexed citations
6.
Hao, Bo, Fang Li, Xiaoxia Wan, et al.. (2022). Squamous cell carcinoma predicts worse prognosis than adenocarcinoma in stage IA lung cancer patients: A population-based propensity score matching analysis. Frontiers in Surgery. 9. 944032–944032. 6 indexed citations
7.
Pan, Shize, Congkuan Song, Heng Meng, et al.. (2022). Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance. Frontiers in Pharmacology. 13. 934722–934722. 11 indexed citations
8.
Song, Congkuan, Zilong Lu, Donghang Li, et al.. (2022). Identification of an inflammatory response signature associated with prognostic stratification and drug sensitivity in lung adenocarcinoma. Scientific Reports. 12(1). 10110–10110. 5 indexed citations
9.
Hao, Bo, Zilong Lu, Juan Xiong, et al.. (2022). Single-cell RNA sequencing analysis revealed cellular and molecular immune profiles in lung squamous cell carcinoma. Translational Oncology. 27. 101568–101568. 18 indexed citations
10.
Pan, Shize, Lei Chen, Tao Fan, et al.. (2022). Comprehensive molecular analysis of a four-pyroptosis-gene signature with prognosis and immune landscape in lung adenocarcinoma. Genomics. 114(3). 110355–110355. 6 indexed citations
11.
Song, Congkuan, Shize Pan, Donghang Li, et al.. (2022). Comprehensive analysis reveals the potential value of inflammatory response genes in the prognosis, immunity, and drug sensitivity of lung adenocarcinoma. BMC Medical Genomics. 15(1). 198–198. 3 indexed citations
12.
Pan, Shize, Heng Meng, Tao Fan, et al.. (2022). Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma. Frontiers in Genetics. 13. 10 indexed citations
13.
14.
Fan, Tao, Shize Pan, Shuo Yang, et al.. (2021). Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma. Frontiers in Immunology. 12. 693062–693062. 14 indexed citations
15.
Fan, Tao, Shuo Yang, Zhixin Huang, et al.. (2020). Autophagy decreases alveolar epithelial cell injury by regulating the release of inflammatory mediators. Journal of Cellular Physiology. 235(11). 7982–7995. 5 indexed citations
16.
Mao, Zhangfan, Xiaoling Shen, Ping Dong, et al.. (2018). Fucosterol exerts antiproliferative effects on human lung cancer cells by inducing apoptosis, cell cycle arrest and targeting of Raf/MEK/ERK signalling pathway. Phytomedicine. 61. 152809–152809. 38 indexed citations
17.
Fan, Tao, Wei Wang, Boyou Zhang, et al.. (2016). Regulatory mechanisms of microRNAs in lung cancer stem cells. SpringerPlus. 5(1). 1762–1762. 18 indexed citations
18.
Fan, Tao, Zhixin Huang, Lei Chen, et al.. (2016). Associations between autophagy, the ubiquitin-proteasome system and endoplasmic reticulum stress in hypoxia-deoxygenation or ischemia-reperfusion. European Journal of Pharmacology. 791. 157–167. 37 indexed citations
19.
Fan, Tao, Lei Chen, Zhixin Huang, et al.. (2016). Autophagy decreases alveolar macrophage apoptosis by attenuating endoplasmic reticulum stress and oxidative stress. Oncotarget. 7(52). 87206–87218. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026